Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Virbac makes medicines, vaccines, and health products for pets and farm animals, selling them mainly to veterinarians.
Virbac is a French animal-health company. It makes the medicines, vaccines, and everyday care products that veterinarians reach for when a dog, cat, or cow gets sick. The customer is usually not the pet owner directly — it is the vet, the clinic, or the farmer, who chooses which product to use and then sells or applies it.
The business splits into two broad halves. Companion animals — dogs and cats — are the bigger and faster-growing part, covering things like dental chews, skin treatments, and vaccines. Farm animals — cattle, pigs, poultry — are the other half, where the products help keep livestock healthy and productive. The company also sells some products straight to pet owners, such as food and hygiene items. It operates across Europe, the Americas, and Asia-Pacific, and it has grown by buying smaller animal-health brands to widen its lineup. Why do vets pick Virbac over rivals like Zoetis or Boehringer Ingelheim? Mostly because animal health is a trust business. A vet sticks with brands that work and that clients accept, so switching costs are real but not enormous. Virbac is a mid-sized player in a market dominated by much larger companies, which means it wins on focus and niche products rather than sheer scale. It spends heavily on research and development to keep launching new treatments.
The pet boom of recent years has been a tailwind: more pets, more spending on them, and more willingness to pay for vet care. Virbac has also pushed into the fast-growing dental and dermatology segments for pets. It pays a dividend and invests in its own factories and product pipeline. The main risks are plain: animal-health spending can slow, larger competitors can outspend it, and a single weak product launch or a supply snag at a plant can dent results.
Saved answer · last researched 15 Nov 2026